Sales decline 51.96% to Rs 1.35 crore
Net profit of Vivanza Biosciences declined 34.62% to Rs 0.17 crore in the quarter ended September 2022 as against Rs 0.26 crore during the previous quarter ended September 2021. Sales declined 51.96% to Rs 1.35 crore in the quarter ended September 2022 as against Rs 2.81 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales1.352.81 -52 OPM %-2.221.42 -PBDT0.16-0.03 LP PBT0.16-0.03 LP NP0.170.26 -35Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content